Arformoterol Tartrate Solution
Product Images NDC 70748-175

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Arformoterol Tartrate (NDC 70748-175). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (65d81c00 8791 4937 8e25 4abfc9790e4b 01)

Chemical structure diagram of Arformoterol tartrate, showing the molecular configuration of the active ingredient as depicted in the image.*

FDA Label Image

Image (65d81c00 8791 4937 8e25 4abfc9790e4b 02)

A line graph showing the mean change from baseline FEV1 (L) over 12 hours postdose comparing Placebo and 15 mcg Arformoterol Tartrate Inhalation Solution BID. The graph plots hours postdose on the x-axis and mean change in FEV1 on the y-axis, illustrating higher and sustained mean increases for the Arformoterol Tartrate group versus Placebo.*

FDA Label Image

Image (65d81c00 8791 4937 8e25 4abfc9790e4b 03)

A line graph showing mean change from baseline FEV1 (lung function) over 12 hours postdose. It compares placebo and 15 mcg Arformoterol tartrate inhalation solution BID, with time on the x-axis and mean change in liters on the y-axis. Arformoterol shows a higher increase in FEV1 compared to placebo across the time period.*

FDA Label Image

Image 1 (65d81c00 8791 4937 8e25 4abfc9790e4b 04)

FDA Label Image

Image (65d81c00 8791 4937 8e25 4abfc9790e4b 05)

An instructional illustration showing a close-up of a hand holding a small vial or ampule, with an arrow indicating the direction to twist or snap the top off for opening.*

FDA Label Image

Image (65d81c00 8791 4937 8e25 4abfc9790e4b 06)

An instructional illustration showing a hand holding and inserting a liquid into a reservoir labeled 'RESERVOIR.' The image appears to demonstrate the step of adding a solution to a device, likely related to the respiratory inhalation product Arformoterol tartrate solution.*

FDA Label Image

Image (65d81c00 8791 4937 8e25 4abfc9790e4b 07)

An instructional diagram showing a respiratory solution device with a labeled mouthpiece attachment, likely illustrating how to connect or use the mouthpiece for inhalation.*

FDA Label Image

Figure 4 (65d81c00 8791 4937 8e25 4abfc9790e4b 08)

Black and white line drawing showing a face mask intended for respiratory inhalation use. The mask is labeled 'FACE MASK' and appears attached to a device or apparatus on its right side, likely illustrating the correct placement or connection for inhalation treatment.*

FDA Label Image

Image (65d81c00 8791 4937 8e25 4abfc9790e4b 09)

An illustration showing a device labeled as a 'compressor' with a knob and meter, connected to tubing. The tubing is labeled and shown extending out of the compressor device.*

FDA Label Image

Image (65d81c00 8791 4937 8e25 4abfc9790e4b 10)

An instructional illustration showing a person holding an inhalation device near their mouth, demonstrating how to use the respiratory inhalation solution Arformoterol tartrate 15 ug/2mL by Lupin Pharmaceuticals, Inc.*

FDA Label Image

Image 2 (65d81c00 8791 4937 8e25 4abfc9790e4b 11)

FDA Label Image

Pouch (65d81c00 8791 4937 8e25 4abfc9790e4b 12)

Label for Arformoterol Tartrate 15 mcg/2 mL inhalation solution by Lupin Pharmaceuticals, Inc. It is a sterile unit-dose vial with a dosage of 15 micrograms per 2 mL. The label includes storage and administration instructions, barcodes, and manufacturer information, emphasizing the solution is for respiratory inhalation use and prescription only.*

FDA Label Image

Carton (65d81c00 8791 4937 8e25 4abfc9790e4b 13)

Packaging label for Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL by Lupin Pharmaceuticals, Inc. The label indicates a prescription-only inhalation solution intended for respiratory use, packaged as 30 sterile unit-dose vials of 2 mL each. Storage instructions advise refrigeration or room temperature storage for up to 6 weeks.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.